HIV News and Research

RSS

Adolescent health programs receive only a tiny share of international aid, finds research

Melbourne's Murdoch Children's Research Institute, in partnership with Harvard Medical School, has discovered that adolescent health programs across the developing world receive only a tiny share of international aid, even though young people make up 30 percent of the population of low-income countries.

10 Aug 2018

Supercomputer simulations reveal potential therapeutic target in HIV-1 replication

HIV-1 replicates in ninja-like ways. The virus slips through the membrane of vital white blood cells. Inside, HIV-1 copies its genes and scavenges parts to build a protective bubble for its copies.

10 Aug 2018

FIND and genedrive announce study agreement to evaluate HCV ID Kit

genedrive plc, a near patient molecular diagnostics company, and the Foundation for Innovation of New Diagnostics (FIND), announced today a study agreement for the performance evaluation of genedrive plc’s hepatitis C virus (HCV) Genedrive HCV ID Kit.

10 Aug 2018

New method evaluates effectiveness of interventions in mitigating spread of HIV

Using genetic sequencing to understand the evolutionary relationships among pathogens, an international team of researchers-;including several from the Center for Drug Use and HIV/HCV Research at New York University-;has developed a new method to determine how effective interventions are against the spread of infectious diseases like HIV.

9 Aug 2018

Research findings open door to promising HIV treatments

New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

9 Aug 2018

Researchers find faster way to analyze outcome of experimental vaccines

A team at Scripps Research has come up with a faster way to analyze the outcome of experimental vaccines against HIV and other pathogens.

9 Aug 2018

Extended-release naltrexone appears to help HIV-positive patients reduce heavy drinking

Extended-release naltrexone -- an injection that decreases heavy drinking in the general population when taken in conjunction with counseling -- appears to help HIV-positive individuals reduce their number of heavy drinking days too, say Yale researchers.

7 Aug 2018

Scientists identify two potential new drug targets for treatment of HIV

Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV-;the virus that causes AIDS-;and the hepatitis C virus.

7 Aug 2018

Researchers examine impact of age and ethnicity on HIV testing

Many barriers prevent people from getting tested for HIV, including lack of knowledge, competing priorities during medical visits, and stigma associated with the test on the part of both the patient and provider.

3 Aug 2018

Study highlights impact of silent viruses on how the host responds to vaccines

UC Davis researchers have shown that low levels of cytomegalovirus (CMV) have a significant impact on microbe and immune cell populations and how the immune system responds to the influenza vaccine. The study was published in the Journal of Virology.

3 Aug 2018

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

AstraZeneca and Merck, known as MSD outside the U.S. and Canada, today announced that the European Medicines Agency (EMA) has granted orphan designation to selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1).

3 Aug 2018

MGH researchers explore how genetic abnormality in Ewing sarcoma unleashes tumor growth

A Massachusetts General Hospital research team has used epigenome editing tools to investigate how the genetic abnormality that drives Ewing sarcoma - the second most common bone cancer in children and young adults - unleashes tumor growth.

2 Aug 2018

Computer simulations can accurately predict transmission of HIV

In a recently published study in the journal Nature Microbiology, researchers at Los Alamos National Laboratory show that computer simulations can accurately predict the transmission of HIV across populations, which could aid in preventing the disease.

1 Aug 2018

Researchers find possible active substance that may cure hepatitis E

An international team of researchers has now found a possible active substance against the virus in the naturally occurring substance silvestrol.

1 Aug 2018

Researchers describe strategy used by Oropouche virus to replicate in human cells

The strategy used by the Oropouche virus to replicate in human cells has been described for the first time by researchers at the University of São Paulo in Brazil and international collaborators in an article published in the journal PLOS Pathogens.

31 Jul 2018

Scientific group takes new step towards designing new HIV vaccine

The scientific group of Peter the Great St.Petersburg Polytechnic University headed by Professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine.

31 Jul 2018

Fucose-based food supplement could be used to stop the spread of norovirus in children's hospitals

Norovirus is the most common cause of gastroenteritis worldwide; it causes tens hundreds of thousands of deaths each year and is particularly risky for children under 3 years old.

27 Jul 2018

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

An estimated 2.3 million people globally are infected with both human immunodeficiency virus type 1 and hepatitis C virus.

27 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

Long-lasting control of HIV infection without antiretroviral therapy is a feasible goal that deserves vigorous pursuit, Anthony S. Fauci, M.D., will assert during a lecture on Wednesday, July 25 at the 22nd International AIDS Conference in Amsterdam.

26 Jul 2018

HIV News and Research

Adolescent health programs receive only a tiny share of international aid, finds research

Supercomputer simulations reveal potential therapeutic target in HIV-1 replication

FIND and genedrive announce study agreement to evaluate HCV ID Kit

New method evaluates effectiveness of interventions in mitigating spread of HIV

Research findings open door to promising HIV treatments

Researchers find faster way to analyze outcome of experimental vaccines

Extended-release naltrexone appears to help HIV-positive patients reduce heavy drinking

Scientists identify two potential new drug targets for treatment of HIV

Researchers examine impact of age and ethnicity on HIV testing

Study highlights impact of silent viruses on how the host responds to vaccines

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

MGH researchers explore how genetic abnormality in Ewing sarcoma unleashes tumor growth

Computer simulations can accurately predict transmission of HIV

Researchers find possible active substance that may cure hepatitis E

Researchers describe strategy used by Oropouche virus to replicate in human cells

Scientific group takes new step towards designing new HIV vaccine

Fucose-based food supplement could be used to stop the spread of norovirus in children's hospitals

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

CNDA approves KEYTRUDA for treatment of advanced melanoma

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News